Daily Endocrinology Research Analysis

In 4,829 UK Biobank participants with type 2 diabetes followed for a mean of 11.3 years, higher adherence to an overall plant-based dietary index was associated with lower all-cause mortality (T3 vs T1 HR 0.79), while an unhealthy plant-based index was linked to higher mortality (HR 1.24). Associations were stronger among those with poor glycemic control, larger waist circumference, earlier age at diagnosis, and longer diabetes duration.

Impact: This well-designed prospective cohort links diet quality to mortality in type 2 diabetes and identifies high-risk subgroups who may derive greater benefit, directly informing nutritional counseling.

Clinical Implications: Clinicians should emphasize healthier plant-based dietary patterns (e.g., vegetables, fruits, whole grains, legumes, nuts) while discouraging unhealthy plant-based choices (refined grains, sweets, sugar-sweetened beverages). Patients with poor glycemic control or central obesity may benefit most.

Future Directions: Randomized dietary interventions in type 2 diabetes targeting plant-forward diets, with stratification by glycemic control and adiposity, and mechanistic studies linking specific plant foods to cardiometabolic pathways.

In insulin-deficient mice, the liver immune niche is remodeled with reduced T cells and polarized Kupffer cells. S100A9 treatment, acting via TLR4, rescued Kupffer cell polarization and corrected lipid and ketone abnormalities, reducing hypertriglyceridemia and hyperketonemia; it also increased skeletal muscle glucose uptake, improving hyperglycemia.

Impact: This study identifies the S100A9–TLR4 axis as a lever to reprogram tissue-resident immune niches and improve multiple metabolic derangements in insulin deficiency, opening a tractable therapeutic avenue.

Clinical Implications: Suggests immunomodulatory strategies (e.g., S100A9-based approaches or TLR4-targeting) could complement insulin therapy by mitigating hypertriglyceridemia, hyperketonemia, and hyperglycemia in insulin-deficient states; translation will require rigorous safety and dose-ranging studies.

Future Directions: Define cellular and molecular intermediates linking S100A9–TLR4 signaling to metabolic fluxes; evaluate pharmacology, safety, and efficacy in larger animal models; explore combinatorial strategies with insulin in diabetic ketoacidosis-prone settings.

In Chinese cohorts, circulating remnant cholesterol associated with multiple cardiovascular outcomes. A GWAS (n=14,939) identified seven loci for RC. Two-sample Mendelian randomization using Biobank Japan showed genetically higher RC increased cardiovascular risks, notably aortic aneurysm (OR 1.82 per SD). Replication in European datasets supported the findings, establishing RC as a causal CVD risk factor in East Asians.

Impact: By integrating ancestry-specific GWAS with Mendelian randomization and replication, this study provides strong causal evidence that remnant cholesterol drives CVD in East Asians, informing targeted prevention.

Clinical Implications: Risk stratification and prevention in East Asians should prioritize lowering remnant cholesterol (e.g., targeting triglyceride-rich lipoproteins via fibrates, omega-3s, ApoC-III/ANGPTL3 inhibition), complementing LDL-C lowering.

Future Directions: Intervention trials targeting remnant cholesterol in East Asians; development of precise RC assays; exploration of gene–environment interactions and ancestry-informed risk algorithms.